Trial Profile
Comparative study of ablative efficacy of intravesical chemotherapy using gemcitabine and mitomycin C with mitomycin C alone for non-muscle invasive bladder carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2015
Price :
$35
*
At a glance
- Drugs Gentamicin (Primary) ; Mitomycin
- Indications Bladder cancer
- Focus Therapeutic Use
- 13 Jul 2015 New trial record
- 02 Jun 2015 Patients were enrolled between Feb 2009 and January 2011, according to ASCO 2015 abstract.
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO 2015).